Results 281 to 290 of about 114,365 (325)

Novel Group of Imidazole Derivatives as Atypical Selective Cyclooxygenase-2 Inhibitors: Design, Synthesis and Biological Evaluation.

, 2018
Azin Kiani, Elham Rezaee, Sayyed Abbas Tabatabai   +2 more
openalex   +1 more source

Cell‐Free DNA‐Based Theranostics for Inflammatory Disorders

Advanced Science, EarlyView.
Summary on the dual potential of cfDNA as biomarkers and therapeutic targets for inflammatory disorders. Figure was created with BioRender.com. ABSTRACT Inflammatory disorders are characterized by immune‐mediated inflammatory cascades that can affect multiple organs.
Jiatong Li, Yumei Wang, Xiaoxi Fan, Miao Xu, Jiawen Li, Wenfei Tan, Jianxiang Zhang, Heran Li   +7 more
wiley   +1 more source

Optimising Pain Relief in Acute Pancreatitis: An Evidence-Based Approach. [PDF]

J Clin Med
Knoph CS, Pandanaboyana S.
europepmc   +1 more source

Effects on Oral Squamous Carcinoma Cell Lines and Their Mechanisms of Pyrazole N-Aryl Sulfonate: A Novel Class of Selective Cyclooxygenase-2 Inhibitors. [PDF]

Int J Mol Sci
Wang S, Shi M, Wang H, Zeng X, Zhang D, Zhang Z, Xu Z, Li Y.   +7 more
europepmc   +1 more source

Transient receptor potential melastatin 6 and transient receptor potential melastatin 6/7 antagonists suppress colon adenocarcinoma HT-29 cells. [PDF]

World J Gastrointest Oncol
Kampuang N, Chamniansawat S, Pongkorpsakol P, Treveeravoot S, Thongon N.   +4 more
europepmc   +1 more source

Diagnosis and Management of Hypersensitivity to Antiplatelet Drugs: EAACI Position Paper. [PDF]

Allergy
Cortellini G, Nakonechna A, Barbaud A, Bavbek S, Calogiuri G, Doña I, Kvedariene V, Laguna Martinez JJ, Liberati S, Pagani M, Romano A.   +10 more
europepmc   +1 more source

Cyclooxygenase-2 expression in advanced oral squamous cell carcinoma: a biomarker of poor prognosis. [PDF]

BMC Oral Health
Chen X, Ouyang Q, Fan R, Luo L, Mai H.
europepmc   +1 more source

Radiolabeled <i>para</i>-I-nimesulide: an unexpected tracer for imaging peripheral inflammation. [PDF]

Front Nucl Med
Yamamoto Y, Imai K, Saito Y, Yamamoto F.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Cyclooxygenase-2 inhibitors

Current Opinion in Internal Medicine, 2006
The purpose of this review is to summarize new information regarding the use of selective inhibitors of the cyclooxygenase-2 enzyme, emphasizing recent developments regarding cardiovascular risk.Selective cyclooxygenase-2 inhibitors are as effective as nonselective nonsteroidal antiinflammatory drugs in relieving pain and inflammation but are ...
Christopher J, Hawkey, Paul J, Fortun
  +5 more sources

Cyclooxygenase‐independent actions of cyclooxygenase inhibitors

The FASEB Journal, 2001
Several studies have demonstrated unequivocally that certain nonsteroidal anti‐inflammatory drugs (NSAIDs) such as sodium salicylate, sulindac, ibuprofen, and flurbiprofen cause anti‐inflammatory and antiproliferative effects independent of cyclooxy‐genase activity and prostaglandin synthesis inhibition.
I, Tegeder, J, Pfeilschifter, G, Geisslinger   +2 more
openaire   +2 more sources